GLOW

GLOW is a three-component research formulation containing GHK-Cu (50 mg), BPC-157 (10 mg), and TB-500 (10 mg). These compounds are studied individually and in combination in laboratory models involving peptide signaling, cellular migration, copper-dependent pathways, and extracellular-matrix activity. RESEARCH FOCUS • Cellular and peptide signaling • Extracellular-matrix activity • Cell migration and structural-protein research • Copper-dependent biological pathways • Multi-peptide interaction studies GLOW and its constituent research compounds have not been approved by the FDA for therapeutic use. This product is offered exclusively for laboratory research use only. It is not intended for human or animal consumption, diagnostic use, therapeutic use, or clinical application.